When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – For hepatocellular carcinomas (HCC) larger than 2 cm, radiofrequency ablation (RFA) is the best ablative therapy, a meta-analysis shows – but for smaller…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy can significantly improve event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer, according to…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses uveal melanoma treatment which depends on saving the patient’s life before consideration of saving the eye…
NEW YORK (Reuters Health) – A substantial proportion of women with cervical cancer who receive curative-intent radiotherapy will soon develop pelvic fractures, clinicians from the University of Texas…
NEW YORK (Reuters Health) – In HIV-infected patients, risk factors for thrombocytopenia include interruptions in antiretroviral therapy, high HIV RNA levels, hepatitis C virus (HCV) infection, and cirrhosis,…
NEW YORK (Reuters Health) – Although patients with liver disease often have an increased international normalized ratio (INR), their coagulopathy does not protect against venous thromboembolism (VTE), new…
NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
